- Home
- RXST vs PSEC Comparison
RXST vs PSEC Comparison
Compare RXST & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RXST | PSEC |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.6M | 1.2B |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RXST | PSEC |
|---|---|---|
| Price | $11.01 | $2.53 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 11 | 1 |
| Target Price | ★ $11.30 | $2.50 |
| AVG Volume (30 Days) | 807.7K | ★ 3.7M |
| Earning Date | 11-05-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 21.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $142,085,000.00 | ★ $680,752,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.75 | N/A |
| 52 Week Low | $6.32 | $2.45 |
| 52 Week High | $37.13 | $4.47 |
Technical Indicators
Market Signals| Indicator | RXST | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 41.52 |
| Support Level | $10.46 | $2.45 |
| Resistance Level | $13.14 | $2.71 |
| Average True Range (ATR) | 0.66 | 0.06 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 20.29 | 29.17 |
Price Performance
Historical ComparisonAbout RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.